Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Top Stock Reports for Coca-Cola, Merck & Toyota Motor
08:05pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Company (KO), Merck & Co., Inc. (MRK) and Toyota Motor Corp. (TM).
Moderna (MRNA) Bivalent COVID Booster Effective Against BA.4/5
07:16pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Moderna's (MRNA) bivalent COVID booster candidate exhibits a higher antibody response against all-tested COVID-19 variants, including the Omicron subvariants BA.4 and BA.5.
Exelixis (EXEL) Cabometyx Combo Study Meets Primary Goal
03:57pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Exelixis'(EXEL) late-stage study evaluating the combination of Cabometyx and Opdivo and Yervoy demonstrates significant improvement in progression-free survival at the primary analysis.
Pliant Therapeutics (PLRX) Up on Positive Data From Lung Disease Study
03:01pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Pliant Therapeutics (PLRX) reports favorable data from a mid-stage study, which supports the potential of PLN-74809, its experimental drug candidate for treating IPF.
Here's Why You Should Retain Walgreens Boots (WBA) For Now
02:58pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Investors are optimistic about Walgreens Boots (WBA), given its better-than-expected earnings and strategic alliances.
Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners
01:00pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Investors Bought This Pharma Stock Despite the Dow's 164-Point Drop Today
09:14pm, Monday, 11'th Jul 2022 The Motley Fool
The Dow struggled today, as investors prepared for a busy week full of new economic data and the beginning of earnings season.
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
07:17pm, Monday, 11'th Jul 2022 Zacks Investment Research
Pfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full approval in the United States for use in adolescents aged 12 years and older.
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
04:59pm, Monday, 11'th Jul 2022
Pfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full approval in the United States for use in adolescents aged 12 years and older.
Henry Schein's (HSIC) New Buyout Expands Its Switzerland Base
03:45pm, Monday, 11'th Jul 2022 Zacks Investment Research
Henry Schein (HSIC) serves the Swiss dental implant market through its Basel-based division, Camlog Biotechnologies GmbH, since 2004.
Quest Diagnostics (DGX), CDC Sign New COVID-19 Testing Deal
02:41pm, Monday, 11'th Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) and the CDC tie up to provide COVID testing for underserved communities free of cost across the United States.
Final Trades: Merck, Wynn Resorts & more
02:30pm, Monday, 11'th Jul 2022
The "Halftime Report" traders give their top picks to watch for the second half.
What Stocks To Buy Today? 5 Dividend Stocks To Watch In This Bear Market
02:15pm, Monday, 11'th Jul 2022
Which of these dividend stocks do you have on your watchlist right now?
The Zacks Analyst Blog Highlights Coca-Cola, Home Depot, Merck and JPMorgan Chase
10:23am, Monday, 11'th Jul 2022 Zacks Investment Research
Coca-Cola, Home Depot, Merck and JPMorgan Chase are part of Zacks Top Analyst Blog.
What's Happening With Merck Stock?
06:30am, Monday, 11'th Jul 2022
Merck stock (NYSE: MRK) has seen a 21% rise YTD, significantly outperforming its peers and the broader markets, with Johnson & Johnson stock up 4%, Pfizer stock down 6%, AbbVie stock up 12%, and the S
